Signaling its plan to expand its business model in the Pacific Rim and build a global presence as a large imaging and cardiac safety core lab, CoreLab Partners is opening of an office in Tokyo under the wholly owned subsidiary CoreLab Partners Japan.

“This expanded presence is a natural extension of our geographic reach and global strategy to serve our growing base of multinational biopharma companies operating in the region and will complement our operational capability which was established in Shanghai, China over a decade ago,” said CoreLab Partners’ president and CEO, Dr. Mike Woehler. 

CoreLab Partners currently has a business alliance in Japan with Suzuken, which markets its cardiac safety services.

“CoreLabs has been present in the region since 1999 and has conducted hundreds of drug development studies in both cardiac safety and imaging for a variety of sponsor partners.  The addition of a local regional director and business development professional will allow CoreLab Partners to better service our client base by nurturing current relationships and opening up new markets for our full line of cardiac safety and imaging services” said Kevin Duffy, vice president, global business development.